Mechanisms of action of peptide immunotherapy for type 1 diabetes : characterising T-cells induced or modified by proinsulin C19-A3
Peptide immunotherapy (PIT) is a specific immunomodulatory treatment aiming to tip the balance from pro8inflammatory attack to restoration of immune tolerance. It has been successfully translated into clinical practice in the field of allergy, stimulating ongoing research in autoimmune diseases incl...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2018
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733448 |